$2.75
N/A
Last update: Oct 1, 1:15 PM
HLS THERAPEUTICS INC by HLS Therapeutics Inc. (HLTRF) Stock Price, Quote, News & History
HLTRFOTCPK
Raymond James analyst Rahul Sarugaser maintains HLS Therapeutics (OTC:HLTRF) with a Market Perform and lowers the price target from $6.5 to $5.
You can purchase shares of HLS THERAPEUTICS INC by HLS Therapeutics Inc. (OTCPK:HLTRF) through any online brokerage.
There are no as such competitors for HLS THERAPEUTICS INC by HLS Therapeutics Inc..
HLS THERAPEUTICS INC by HLS Therapeutics Inc. has a consensus price target of $5.00.
The stock price for HLS THERAPEUTICS INC by HLS Therapeutics Inc. (OTCPK: HLTRF) is $2.75 last updated October 1, 2026 at 1:15 PM EDT.
There are no upcoming dividends for HLS THERAPEUTICS INC by HLS Therapeutics Inc..
HLS THERAPEUTICS INC by HLS Therapeutics Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for HLS THERAPEUTICS INC by HLS Therapeutics Inc..
HLS THERAPEUTICS INC by HLS Therapeutics Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company's products include Clozaril, Vascepa, CSAN Pronto, and...
